Scouring sources for information on GLP1 Agonist drugs, so you don't have to.
One of the best things about the internet is the meeting of ideas. People discuss things, squabble, research, disagree, and we figure out just a little more about the truth. Recently I saw a great comment that gently suggested that insulin management is the real problem in weight loss. You
topic:insurance
You'd think that GLP1 Receptor Agonist treatments, which help treat type 2 diabetes and help with weight management (and thus avoid some bad potential outcomes like Heart Disease or Diabetes) would be loved by insurance companies. 🍃Don't know what a GLP1 Receptor Agonist is, or how
Pricing Roundups
Last updated: February 2024 Here's what we can find on pricing for GLP1 Receptor Agonists – Ozempic, Wegovy, Rybelsus, Zepbound, Mounjaro and more. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out our quick explainer Before
Research Roundups
GLP1 Receptor Agonist drugs (Semaglutide, Ozempic, Mounjaro, Wegovy, etc) have seen extensive testing and research in the past, due to their usage by people with type 2 Diabetes. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out
A list of medical professionals and researchers from major universities and organizations: * Yale New Haven Health * Yale School of Medicine * Brigham and Women's Hospital * University of California, San Francisco Have petitioned the World Health Organization (WHO) to add GLP1 Receptor Agonists to the list of essential medicines for
Many opponents of GLP1 Receptor Agonist drugs (ex. Semaglutide, and Tirzepatide with brand names like Ozempic, Wegovy, Mounjaro, etc) caution that as the drugs must be taken continuously, people experience rapid weight gain after getting off the drugs – all the way up to their starting weight. 🍃Don't know
Across the internet, people are reporting and talking about losing weight with GLP1 Receptor Agonist drugs: * Semaglutide (Ozempic, WeGovy, Rybelsus) * Tirzepatide (Mounjaro, Zepbound) * Exenatide (Byetta) * Liraglutide (Victoza, Saxenda) 🍃Don't know what a GLP1 Receptor Agonist is? Check out our quick explainer What people are saying around the internet
tl;dr - No, unless you have infinite money and an infinite appetite for side effects, and are fine with possibly losing too much muscle mass. GLP1 Receptor Agonists (Semaglutide, Liraglutide, Exenatide, etc) are not miracle drugs. Whether pursuing weight loss goals or trying to manage a case of type
Ozempic remains the most talked about GLP1 Receptor Agonist drug on the market today, even though it's not technically approved for weight loss by the FDA. 🍃Don't know what a GLP1 Receptor Agonist is? Check out our quick explainer Celebrities, News shows, podcasts – everyone is talking
Eli Lilly and Novo Nordisk have been in competition for a long time. Both companies sell insulin for type 2 diabetes and both sell treatments in the form of GLP1 Receptor Agonist drugs – Semaglutide (made by Novo Nordisk) and Tirzepatide (made by Eli Lilly). 🍃Don't know what a
The folks over at the Acquired podcast have put together a fantastic deep dive podcast on Novo Nordisk, and it's a great listen. What is Novo Nordisk? Novo Nordisk (Wikipedia) is the multinational pharmaceutical company from Denmark which invented Semaglutide. While the name "Semaglutide" may not
The STEP1 Trials which were conducted in June 2018 were already a great step forward for the treatment of type 2 diabetes and weight control, but as with the best science, it's always good to confirm, repeat and conduct experiments to find truth. 📑Want to read more about